#United Kingdom #Radiation Therapy #Leo Cancer Care #Crawley #Marie®

Leo Cancer Care Receives CE Mark for Marie®

In a landmark development for radiation therapy in Europe, Leo Cancer Care recently announced the achievement of CE marking for its flagship upright radiation therapy system, Marie®. This significant approval not only paves the way for commercial deployment across Europe but also marks a transformative shift in how radiation treatments are delivered, emphasizing patient comfort and care.

Traditionally, patients undergoing radiation therapy are required to lie flat and stay still, an approach that has dictated everything from system design to clinical workflows for decades. The introduction of the Marie® system challenges this conventional practice by allowing treatments to be administered while patients are in an upright position. This innovative design aims to put patients at the center of their care journey, creating a more natural and pleasant treatment experience.

A New Paradigm in Cancer Treatment

Stephen Towe, CEO of Leo Cancer Care, elaborated on the impact of Marie®, stating, "This is more than just a regulatory milestone; it signifies the moment upright radiation therapy becomes a clinical reality for patients in Europe. Marie® redefines what is possible in cancer treatment by combining human-centric design with the flexibility to support both existing and emerging treatment modalities."

The ability to administer treatment while patients are upright not only improves patient experience but also has the potential to streamline the design of treatment rooms and enhance operational efficiency in cancer centers.

The Future-Ready Platform: Marie®

Marie® stands out as the first of its kind to integrate vertical patient positioning with a radiation-independent architecture compatible with various particle therapy techniques. This positions it not only as an innovative solution but also as a robust platform for the next generation of radiation therapy.

Some key benefits of using Marie® include:

• - A more comfortable and natural treatment experience for patients.
• - Enhanced treatment options, including support for adaptive online and arc therapy.
• - Improved accessibility for facilities that cannot implement traditional particle therapy solutions.
• - A flexible platform designed to accommodate future advancements in radiation therapy.

Regulatory Achievements and Partnerships

The CE marking confirms that Marie® meets the highest European standards for safety, performance, and clinical readiness, a culmination of years of research, development, and collaborative clinical efforts with partners across the radiation therapy spectrum. Notably, the Centre Léon Bérard, a prominent institution dedicated to cancer treatment and research, has been a longstanding research partner for Leo Cancer Care. Following the CE marking, this collaboration will expand to focus on anatomical imaging and positioning in an upright posture utilizing Marie’s capabilities.

Pioneering Advancements in Hadron Therapy

For Leo Cancer Care, this milestone is just the beginning as installations in Europe commence with the Centro Nazionale di Adroterapia Oncologica (CNAO) in Italy. They aim to start treatments before the end of the year. Dr. Sandro Rossi, General Director of CNAO, noted, "Integrating the LCC upright positioning system into our clinical workflow is a groundbreaking milestone for CNAO. By combining LCC’s innovative technology with our horizontal multi-ion beam capabilities, we are introducing a highly advanced new treatment method aimed at optimizing treatment precision and fundamentally increasing clinical throughput."

This synergy between upright positioning technology and clinical expertise fortifies their commitment to delivering accessible, patient-centered, personalized oncology solutions. Leo Cancer Care looks forward to a close collaboration with their team in the installation, commissioning, and first patient treatments.

With regulatory approval in hand, Leo Cancer Care is working with other leading cancer centers across Europe to integrate upright radiation therapy into clinical practice, accelerating the rollout of a solution that prioritizes both treatment precision and patient experience.